Defining acceptable limits for the metrological traceability of specific measurands

Renze Bais, Dave Armbruster, Rob T P Jansen, George Klee, Mauro Panteghini, Joseph Passarelli, Ken A. Sikaris

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Although manufacturers are compelled by the European IVD Directive, 98/79/EC, to have traceability of the values assigned to their calibrators if suitable higher order reference materials and/or procedures are available, there is still no equivalence of results for many measurands determined in clinical laboratories. The adoption of assays with metrological traceable results will have a significant impact on laboratory medicine in that results will be equivalent across different laboratories and different analytical platforms. The IFCC WG on Allowable Errors for Traceable Results has been formed to define acceptable limits for metrological traceability chains for specific measurands in order to promote the equivalence of patient results. These limits are being developed based on biological variation for the specific measurands. Preliminary investigations have shown that for some measurands, it is possible for manufacturers to assign values to assay calibrators with a measurement uncertainty that allows the laboratory enough combined uncertainty for their routine measurements. However, for other measurands, e.g., plasma sodium, current assays are too imprecise to fulfil limits based on biological variation. Although an alternative approach based on probability theory is being investigated, the most desirable approach would be for industry to improve measurement methods so that they meet clinical requirements.

Original languageEnglish (US)
Pages (from-to)973-979
Number of pages7
JournalClinical Chemistry and Laboratory Medicine
Volume51
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Assays
Clinical laboratories
Uncertainty
Probability Theory
Medicine
Sodium
Plasmas
Industry

Keywords

  • IFCC
  • Metrological traceability
  • Result equivalence
  • Standardization

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Bais, R., Armbruster, D., Jansen, R. T. P., Klee, G., Panteghini, M., Passarelli, J., & Sikaris, K. A. (2013). Defining acceptable limits for the metrological traceability of specific measurands. Clinical Chemistry and Laboratory Medicine, 51(5), 973-979. https://doi.org/10.1515/cclm-2013-0122

Defining acceptable limits for the metrological traceability of specific measurands. / Bais, Renze; Armbruster, Dave; Jansen, Rob T P; Klee, George; Panteghini, Mauro; Passarelli, Joseph; Sikaris, Ken A.

In: Clinical Chemistry and Laboratory Medicine, Vol. 51, No. 5, 05.2013, p. 973-979.

Research output: Contribution to journalArticle

Bais, R, Armbruster, D, Jansen, RTP, Klee, G, Panteghini, M, Passarelli, J & Sikaris, KA 2013, 'Defining acceptable limits for the metrological traceability of specific measurands', Clinical Chemistry and Laboratory Medicine, vol. 51, no. 5, pp. 973-979. https://doi.org/10.1515/cclm-2013-0122
Bais, Renze ; Armbruster, Dave ; Jansen, Rob T P ; Klee, George ; Panteghini, Mauro ; Passarelli, Joseph ; Sikaris, Ken A. / Defining acceptable limits for the metrological traceability of specific measurands. In: Clinical Chemistry and Laboratory Medicine. 2013 ; Vol. 51, No. 5. pp. 973-979.
@article{9d21ad7af9c74f42af3db15af010035f,
title = "Defining acceptable limits for the metrological traceability of specific measurands",
abstract = "Although manufacturers are compelled by the European IVD Directive, 98/79/EC, to have traceability of the values assigned to their calibrators if suitable higher order reference materials and/or procedures are available, there is still no equivalence of results for many measurands determined in clinical laboratories. The adoption of assays with metrological traceable results will have a significant impact on laboratory medicine in that results will be equivalent across different laboratories and different analytical platforms. The IFCC WG on Allowable Errors for Traceable Results has been formed to define acceptable limits for metrological traceability chains for specific measurands in order to promote the equivalence of patient results. These limits are being developed based on biological variation for the specific measurands. Preliminary investigations have shown that for some measurands, it is possible for manufacturers to assign values to assay calibrators with a measurement uncertainty that allows the laboratory enough combined uncertainty for their routine measurements. However, for other measurands, e.g., plasma sodium, current assays are too imprecise to fulfil limits based on biological variation. Although an alternative approach based on probability theory is being investigated, the most desirable approach would be for industry to improve measurement methods so that they meet clinical requirements.",
keywords = "IFCC, Metrological traceability, Result equivalence, Standardization",
author = "Renze Bais and Dave Armbruster and Jansen, {Rob T P} and George Klee and Mauro Panteghini and Joseph Passarelli and Sikaris, {Ken A.}",
year = "2013",
month = "5",
doi = "10.1515/cclm-2013-0122",
language = "English (US)",
volume = "51",
pages = "973--979",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "5",

}

TY - JOUR

T1 - Defining acceptable limits for the metrological traceability of specific measurands

AU - Bais, Renze

AU - Armbruster, Dave

AU - Jansen, Rob T P

AU - Klee, George

AU - Panteghini, Mauro

AU - Passarelli, Joseph

AU - Sikaris, Ken A.

PY - 2013/5

Y1 - 2013/5

N2 - Although manufacturers are compelled by the European IVD Directive, 98/79/EC, to have traceability of the values assigned to their calibrators if suitable higher order reference materials and/or procedures are available, there is still no equivalence of results for many measurands determined in clinical laboratories. The adoption of assays with metrological traceable results will have a significant impact on laboratory medicine in that results will be equivalent across different laboratories and different analytical platforms. The IFCC WG on Allowable Errors for Traceable Results has been formed to define acceptable limits for metrological traceability chains for specific measurands in order to promote the equivalence of patient results. These limits are being developed based on biological variation for the specific measurands. Preliminary investigations have shown that for some measurands, it is possible for manufacturers to assign values to assay calibrators with a measurement uncertainty that allows the laboratory enough combined uncertainty for their routine measurements. However, for other measurands, e.g., plasma sodium, current assays are too imprecise to fulfil limits based on biological variation. Although an alternative approach based on probability theory is being investigated, the most desirable approach would be for industry to improve measurement methods so that they meet clinical requirements.

AB - Although manufacturers are compelled by the European IVD Directive, 98/79/EC, to have traceability of the values assigned to their calibrators if suitable higher order reference materials and/or procedures are available, there is still no equivalence of results for many measurands determined in clinical laboratories. The adoption of assays with metrological traceable results will have a significant impact on laboratory medicine in that results will be equivalent across different laboratories and different analytical platforms. The IFCC WG on Allowable Errors for Traceable Results has been formed to define acceptable limits for metrological traceability chains for specific measurands in order to promote the equivalence of patient results. These limits are being developed based on biological variation for the specific measurands. Preliminary investigations have shown that for some measurands, it is possible for manufacturers to assign values to assay calibrators with a measurement uncertainty that allows the laboratory enough combined uncertainty for their routine measurements. However, for other measurands, e.g., plasma sodium, current assays are too imprecise to fulfil limits based on biological variation. Although an alternative approach based on probability theory is being investigated, the most desirable approach would be for industry to improve measurement methods so that they meet clinical requirements.

KW - IFCC

KW - Metrological traceability

KW - Result equivalence

KW - Standardization

UR - http://www.scopus.com/inward/record.url?scp=84882241840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882241840&partnerID=8YFLogxK

U2 - 10.1515/cclm-2013-0122

DO - 10.1515/cclm-2013-0122

M3 - Article

C2 - 23525873

AN - SCOPUS:84882241840

VL - 51

SP - 973

EP - 979

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 5

ER -